Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_999_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
26 Мб
Скачать
100
https://t.me/med1917
64. Caspersen CJ, Powell KE, Christenson GM.Physical activity, exercise, and physical tness: denitions and distinctions for health-related research. Public Health Rep. 1985;100(2):126–31.
65. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE.International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.
66. Western B, Demmelmaier I, Vistad I, Hansen BH, Stenling A, Henriksen HB, Nordin K, Blomhoff R, Berntsen S.How many days of continuous physical activity monitoring reliably represent time in different intensities in cancer survivors. PLoS One. 2023;18(4):e0284881.
67. Abernethy AP, Shelby-James T, Fazekas BS, Woods D, Currow DC.The Australia-modied Karnofsky performance status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]. BMC Palliat Care. 2005;4:7.
68. Jones CJ, Rikli RE, Beam WC.A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999;70(2):113–9.
69. Muñoz-Bermejo L, Adsuar JC, Mendoza-Muñoz M, Barrios-Fernández S, Garcia-Gordillo MA, Pérez-Gómez J, Carlos-Vivas J. Test-retest reliability of ve times sit to stand test (FTSST) in adults: A systematic review and meta-analysis. Biology. 2021;10(6):510.
70. Rikli RE, Jones CJ.Functional tness normative scores for community-residing Older adults, ages 60-94. J Ageing Phys Act. 1999;7(2):162–81.
71. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M. Sarcopenia: revised European consensus on denition and diagnosis. Age Ageing. 2019;48(1):16–31.
72. Trutschnigg B, Kilgour RD, Reinglas J, Rosenthall L, Hornby L, Morais JA, Vigano A.Precision and reliability of strength (Jamar vs. Biodex handgrip) and body composition (dual-energy X-ray absorptiometry vs. bioimpedance analysis) measurements in advanced cancer patients. Appl Physiol Nutr Metab. 2008;33(6):1232–9.
73. Ferguson ML, Bauer J, Gallagher B, Capra S, Christie DR, Mason BR.Validation of a malnu­trition screening tool for patients receiving radiotherapy. Australas Radiol. 1999;43(3):325–7.
74. Bauer J, Capra S, Ferguson M.Use of the scored patient-generated subjective global assess­ment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr. 2002;56(8):779–85.
75. Miller J, Wells L, Nwulu U, Currow D, Johnson MJ, Skipworth RJE.Validated screening tools for the assessment of cachexia, sarcopenia, and malnutrition: a systematic review. Am J Clin Nutr. 2018;108(6):1196–208.
76. Price KL, Earthman CP. Update on body composition tools in clinical settings: computed tomography, ultrasound, and bioimpedance applications for assessment and monitoring. Eur J Clin Nutr. 2019;73(2):187–93.
77. Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A. A global clinical measure of tness and frailty in elderly people. Can Med Assoc J. 2005;173(5):489–95.
78. Decoster L, Liposits G, Dumontier C.Frailty screening and comprehensive geriatric assess­ment. In: Gomes F, editor. Frailty in Older adults with cancer. Springer; 2022. p.41–56. link.
springer.com/book/10.1007/978- 3- 030- 89162- 6; Accessed 2 Aug 2023.
79. Esser P, Hartung TJ, Friedrich M, Johansen C, Wittchen HU, Faller H, Koch U, Harter M, Keller M, Schulz H, Wegscheider K, Weis J, Mehnert A. The generalized anxiety disorder screener (GAD-7) and the anxiety module of the hospital and depression scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients. Psycho-Oncology. 2018;27(6):1509–16.
80. Hinz A, Mehnert A, Kocalevent RD, Brahler E, Forkmann T, Singer S, Schulte T.Assessment of depression severity with the PHQ-9in cancer patients and in the general population. BMC Psychiatr. 2016;16:22.
81. Zigmond AS, Snaith RP.The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.
L. Edbrooke etal.
6 Efcacy ofPrehabilitation inAbdominal Cancer Surgery
https://t.me/med1917
82. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, etal. The European Organization for Research and Treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncol­ogy. J Nat Canc Inst. 1993;85(5):365–76.
83. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X.Development and preliminary testing of the new ve-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.
84. Cella D, Lai JS, Chang CH, Peterman A, Slavin M.Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002;94(2):528–38.
85. National Health Service. National cancer patient experience survey 2023. ncpes.co.uk/
interactive- results/. Accessed 2 Aug 2023.
101
Chapter 7
https://t.me/med1917
Elective Surgery forPatients withSubstance Use Disorder or Recent Substance Misuse
TaliaScott andEthanO.Bryson
Abbreviations
AUD Alcohol use disorder AUDIT Alcohol use disorders identication test COPD Chronic obstructive pulmonary disease CUD Cannabis use disorder MI Myocardial infarction NIDA National institute on drug abuse NMDA N-methyl-D-aspartate NSDUH National survey on drug use and health OUD Opioid use disorder PCA Patient-controlled analgesia SAMHSA Substance abuse and mental health services administration SUD Substance use disorder THC tetrahydrocannabinol US United States TSA Total shoulder arthroplasty WHO World Health Organization
T. Scott Department of Anesthesiology, Perioperative and Pain medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA e-mail: talia.scott@mountsinai.org
E. O. Bryson ( Department of Anesthesiology and Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA e-mail: ethan.bryson@mountsinai.org
Switzerland AG 2024 J. Faintuch, S. Faintuch (eds.), Recent Strategies in High Risk Surgery,
https://doi.org/10.1007/978-3-031-56270-9_7
*)
103© The Author(s), under exclusive license to Springer Nature
104
https://t.me/med1917
T. Scott and E. O. Bryson
Introduction
Substance use disorder (SUD), including alcohol use disorder (AUD), affects a sig­nicant percentage of the population worldwide, and up to 16.5% of the United States (U.S.) population alone, which includes persons above the age of 12, are affected [1]. So prevalent is the issue of recreational substance use that one recent study suggests that up to 40% of patients undergoing elective surgery present with a history of recent substance use preoperatively [2]. Substance use is an independent risk factor for increased complications, cost, and length of stay, and should there­fore be taken into consideration when planning for elective surgery [3]. These com­plications can include higher risk of hemorrhage, sepsis, stroke, respiratory issues, renal failure, and issues with wound or graft healing [3]. Patients with a history of substance use are also more likely to have other serious medical conditions, such as liver disease, chronic obstructive pulmonary disease (COPD), and human immuno­deciency virus (HIV) infection [3].
Detecting a substance use disorder perioperatively can be a challenging task. These diagnoses are commonly missed, whether as a result of absent inquiry or an unwillingness on the part of the patient to admit use, either due to the stigma attached to substance use or ignorance of its potential effects during the periop­erative period [4]. Patients may not understand the implications of recent sub­stance use on perioperative outcomes, thinking it is only a concern if they are acutely intoxicated. Because of this, it is essential to explain to patients that dis­closing substance use prior to elective surgery will not be reported to authorities, is protected by the doctor-patient relationship, is essential for safe administration of anesthesia, and has signicant implications for the success of and recovery from surgery. It should be emphasized that asking these types of questions does not imply judgment but are only asked to gain knowledge that is essential to keep the patient safe during the perioperative period and do not necessarily preclude proceeding with the procedure. Clearly, if, on the day of surgery, the patient appears acutely intoxicated, concerns about the ability to fully understand the informed consent process should be evaluated and the elective surgery should be rescheduled.
There is considerable evidence that patients with a current or recent history of drug use or misuse are at a signicantly higher risk for experiencing any number of perioperative complications associated with elective surgery. When it comes to patients with underlying medical conditions, the risk for complications increases substantially, often leading to increased morbidity, longer hospital stays and higher risk for perioperative mortality [3]. According to this recent report, cur­rent or recent drug misuse also has the potential to increase the length of hospital stay resulting in higher costs, regardless of the patient’s age or medical comor­bidities [3].
7 Elective Surgery forPatients withSubstance Use Disorder or Recent Substance Misuse
https://t.me/med1917
105
Consumption Screening
It can be very challenging to identify these patients in the perioperative period as recreational substance misuse if often not disclosed, reported or previously diag­nosed when they present for elective surgery [4]. Despite this, it is estimated that up to 40% of patients presenting for elective surgery do so with a history of recent or current substance misuse which has the potential to increase their risks for periop­erative complications [2]. In the following sections we will discuss the identica­tion, implications, and management of the patient who presents for elective surgery with recent or current substance use.
Commonly Misused Substances
Alcohol
Alcohol is ubiquitous and in many countries social drinking is considered accept­able substance use. That being said, there is a ne line between alcohol use and misuse, with the denition of alcohol misuse varying between cultures, religions and geographical areas. In general, alcohol misuse includes heavy or binge drinking which is beyond the accepted norms for the population, but even regular acceptable consumption has implications for patients presenting for elective surgery. Alcohol use disorder (AUD) encompasses both alcohol misuse and dependence, and involves negative consequences related to use [5]. AUD is a highly prevalent disorder which affects 237 million men and 46 million women worldwide [6]. In the United States alone, AUD affects 13.2% of adult men and 9.5% of adult women [7]. Patients who present for elective surgery should be questioned regarding their specic daily intake as this has signicant implications for anesthesia and post-surgical recovery success.
Identication
While many patients will occasionally drink alcohol, the stigma attached with per­ceived excessive alcohol consumption varies from culture to culture. From the standpoint of the anesthesiologist or surgeon, no judgment is made regarding indi­vidual use, but the quantity and frequency of use must be identied. The Alcohol Use Disorders Identication Test (AUDIT-C) tool consists of three questions that can be used to screen for AUD [8]. The AUDIT-C is scored on a scale of 0–12 (a score of 0 reects no alcohol use).
106
https://t.me/med1917
T. Scott and E. O. Bryson
Implications forSurgery
Intraoperatively, chronic alcohol use can create tolerance, leading to higher anes­thetic requirements, while on the other hand, acute intoxication lowers the anes­thetic requirement [9]. Obviously the patient who presents for elective surgery either acutely intoxicated or who reports same day alcohol use should be resched­uled and encouraged not to drink prior to surgery, but it is more often that the patient who regularly uses or misuses alcohol will under-report their actual consumption.
There appears to be a dose-dependent relationship between alcohol consumption and surgical complications, with one study nding that the complication rate was 50% higher with consumption of three to four drinks daily but climbed to 200–400% higher in those who consumed ve or more drinks a day. These complications included postoperative infection, cardiopulmonary events, and increased bleed­ing [10].
Alcohol Use Disorder is associated with increased length of hospital stay and cost across surgical elds [1113]. These risks are particularly notable in colectomy patients. Colectomies are already one of the most expensive surgeries, costing up to $25,000 [14]. Patients undergoing colectomy with a history of AUD have increased hospital cost from an already high baseline. Even more concerning is that, patients with AUD who undergo this procedure are at increased risk for in-hospital mortal­ity [11].
A history of AUD is also signicant in patients undergoing orthopedic surgery. An association has been demonstrated between alcohol use and decreased bone remodeling in animal models, so it follows that poor post-orthopedic surgery recov­ery in this population [15]. In arthroplasty patients, those with AUD had higher risks of dislocation and readmission [12]. According to the Hospital Readmissions Reduction Program (HRRP), a value-based purchasing program run by the Center for Medicare and Medicaid services (U.S.) designed to reduce avoidable readmis­sions, increases in readmission could lead to nancial repercussions for the hospi­tal [12].
Management Strategies
Preoperative abstinence can have benecial effects. One study found that patients who were abstinent from alcohol for 1month preoperatively had less postoperative arrhythmia, hypoxemia, and myocardial ischemia than those who continued drink­ing [16]. A meta-analysis agreed that 1–2months of abstinence preoperatively was associated with fewer complications, although the effect on mortality was unclear [17]. Cessation of alcohol use should be guided by specialists who will be able to wean the patient from alcohol while limiting risk of withdrawal and also providing psychosocial support.
7 Elective Surgery forPatients withSubstance Use Disorder or Recent Substance Misuse
https://t.me/med1917
107
Tobacco
According to the World Health Organization (WHO), as of 2022, 22.3% of the global population used tobacco (36.7% men and 7.8% women) [18]. While cigarette smoking is the most common form of tobacco use worldwide, tobacco products also include waterpipe tobacco, commonly referred to as hookahs, which have cultural signicance in many populations and are symbolic of friendship, trust, and respect, as the pipes are shared with physically connected inhalation tubes. The tobacco smoked in this manner is inhaled unltered and regular users are often exposed to increased levels of nicotine and other products of combustion which have signi­cant implications for patients during the perioperative period.
Smokeless tobacco products, such as “vapes,” “e-cigarettes,” or other electronic nicotine delivery devices, chewing tobacco, nicotine gum and patches reduce expo­sure to many of the toxic chemicals associated with the inhalation of cigarette smoke but still provide the user with nicotine, which also has signicant implica­tions for the perioperative patient. Although designed as a replacement for ciga­rettes, the popularity of e-cigarette use has risen dramatically among young people, and by 2022 4.5% of middle school students and 16% of high school students in the U.S. had used an e-cigarette in the past 30days compared to approximately 3.7% of adults [19, 20]. In one survey of preoperative patients it was found that 13.9% of those who used e-cigarettes had used them in the last week [21].
Identication
The easiest way to identify patients who use tobacco products is to ask direct ques­tions during the preoperative interview. Unlike alcohol, which patients may mini­mize their actual use, or illicit drugs, which they may deny using altogether, patients who smoke are usually forthcoming when asked. Preoperatively, patients should be screened for both tobacco and nicotine-containing e-cigarette use. Of note, those who use e-cigarettes commonly do not believe the term “smoking” includes e- cigarette use [21]. Patients can then be counseled on smoking cessation and given the appropriate tools, support, and resources to quit successfully.
Implications forSurgery
Individuals who smoke heavily for several years are more prone to developing com­plications in their lungs after surgery, but even those who smoke occasionally or in small quantities may face an elevated risk. Smoking causes airway hyper-reactivity, contributing to pulmonary complications during anesthesia such as laryngospasm, bronchospasm, reintubation, and hypoxemia even in the absence of reactive airway disease. Age and body habitus are also important, with a 6.3x increased risk of pul­monary complications in obese young smokers compared to 2.3x in young smokers
108
https://t.me/med1917
T. Scott and E. O. Bryson
and 1.8x in all smokers [22]. Given these pulmonary risks, it follows that smokers are more likely to be admitted to the ICU postoperatively [23]. In one study the rela­tive risk for any of these pulmonary complications was 1.8 for all smokers but sig­nicantly higher in patients aged 16–39 years (2.3) and jumped to 6.3 if these patients were also obese [22]. In the same study, young smokers with chronic bron­chitis were 25.7 times more likely to experience bronchospasm in the perioperative setting.
In colorectal surgery, current smokers had increased risk of major complications such as infection, cardiac events, and sepsis as well as increased mortality risk. Overall, within 30days of surgery, smokers had a 30% increased risk of sustaining either a major complication or mortality [24]. In total hip arthroplasties, there was a higher rate of revision in patients who smoke [25].
Wound healing is well-known to be impaired in cigarette smokers [26]. Nicotine is thought to directly cause injury to the vascular intima, leading to atherosclerosis. This can be especially detrimental in plastic surgery and surgery involving grafts, as cutaneous tissue beds are most susceptible to decreased blood ow. Particularly in the case of elective surgery, poor wound healing can detrimentally impact the desired outcome [27].
Although e-cigarettes avoid inhalation of combustible material, their use is still associated with pulmonary toxicity including airway hyperreactivity [28]. The nico­tine contained in e-cigarettes stimulates catecholamine release affecting the cardio­vascular system, which in turn can make the effects of anesthetics less predictable [29]. E-cigarette use in total joint arthroplasty patients was associated with longer operative time, hospital length of stay, and readmission [30]. In plastic surgery, those who used e-cigarettes had similar rates of ap necrosis to cigarette smokers, implying that nicotine is the substance toxic to ap survival [31]. E-cigarettes may be a helpful tool in smoking cessation, but their use should be considered when proceeding with elective surgery.
Management Strategies
Smokers who stop at least 6–8weeks prior to elective surgery have been shown to reduce their risk for intraoperative and postoperative complications [32]. Surgery may provide good incentive to quit smoking and may be a good time to quit. One review found that 8% of those who quit do so because of surgery [33]. Additionally, in one study, 28 subjects (46.7%) who were able to stop smoking prior to surgery remained abstinent at follow-up 1year after intervention [34].
The detrimental effects of smoking on surgical outcomes decrease the longer the period between smoking cessation and surgery and each week of cessation can increase the magnitude of this effect by up to 19% [35]. Cessation of greater than 4weeks was associated with a 20% decreased risk of complications compared to cessation of less than 4weeks [36]. The benets of a longer time frame are explained by the weeks to months it can take for the pulmonary cilia to heal and pulmonary function to return, making 8weeks of abstinence before elective surgery ideal [37].
7 Elective Surgery forPatients withSubstance Use Disorder or Recent Substance Misuse
https://t.me/med1917
At a minimum, from an anesthesia standpoint, the patient should not smoke for at least 12h preoperatively so that levels of nicotine and carboxyhemoglobin can decline. Carboxyhemoglobin can signicantly decrease the bioavailability of oxy­gen, which can be catastrophic in patients with a history of coronary artery disease. If a patient with coronary history reports smoking the day of elective surgery, it may be reasonable to postpone the case [38].
109
Marijuana
According to the United States Substance Abuse and Mental Health Services Administration (SAMHSA) National Survey on Drug Use and Health (NSDUH),
52.5 million people aged 12 or older (18.8% of the population) reportedly used marijuana in 2020 [1]. With an increasing move toward decriminalization and legal­ization in many areas, these numbers will undoubtedly increase, either to come in line with true numbers as the stigma of marijuana use is lessened by the elimination of legal consequences or as new users begin to adopt the habit.
Identication
Signs of acute marijuana intoxication include anxiety, tachycardia, decreased short­term memory (the individual may not be able to adequately participate in the preop­erative interview), Dry mouth, conjunctival injection, impaired perception, and motor skills. In chronic users who have not recently used and are not currently under the inuence these ndings are not common. Simply asking about regular marijuana use, however, usually elicits an honest response. In patients who are hesi­tant it is important to emphasize that questions about regular use are not intended to judge but to obtain information important to keep the patient safe during the procedure.
Signs such as a “green tinge” on the tongue (related to inhaling chlorophyll, or articial green dye which is sometimes added to vaping preparations) has been reported, though these signs are non-specic and rare [39].
Screening tests for marijuana use are, as of this writing, only reliable in chronic users and require regular use over a period of 30 or more days to produce a consis­tently positive result. After the initial use, one-third of the major psychoactive com­ponent of marijuana which is tested for, tetrahydrocannabinol (THC), is excreted in the urine. After a single use, THC may be detected on a urine drug screen for 2–3days, though this is not consistently reliable. With chronic use, however, and depending on the test used, the length of time after the last ingestion during which THC can be detected in the urine increases to 1– 4 weeks [40]. False positive drug screen results have been reported in patients who have been taking over the counter medications such as ibuprofen and naproxen [41].
110
https://t.me/med1917
T. Scott and E. O. Bryson
Implications forSurgery
In 2020 a retrospective cohort analysis published by Goel etal. provided signicant evidence that patients with active cannabis use disorder (CUD) who underwent elective surgery were at increased perioperative risk of myocardial infarction (MI) [42]. In this cohort of 27,206 patients the odds of postoperative MI was 1.88 times higher for patients with a reported active cannabis use disorder, as dened by the International Classication of Diseases, Ninth Edition, Clinical Modication (ICD-9-CM) diagnostic codes for cannabis dependence and cannabis abuse. Prior to this, most evidence in the literature regarding recent or chronic marijuana use as related to surgical implications were, in part, extrapolated from studies performed on patients who reported tobacco smoking, and focused on wound healing [43]. While the route of ingestion of cannabis products is important to consider when looking at outcomes such as wound healing related to decreased vascular perfusion related to vasoconstriction and tissue ischemia, the potential for physiological with­drawal symptoms during the perioperative period, when access to cannabis may be limited, is important to consider as a potential etiology for postoperative MI, espe­cially in the chronic user who presents for elective surgery.
Similar to patients who are chronic tobacco smokers, patients who regularly smoke marijuana are subject to the same pulmonary risks outlined above [38]. Additionally, case reports of uvulitis or uvular edema leading to airway obstruction, laryngospasm and bronchospasm while under anesthesia in patients who regularly smoke marijuana highlight the increased risk for these patients who present for elec­tive surgery [4446]. Anecdotal evidence suggests that, much in the same way patients with AUD present with increased tolerance for anesthetic agents, patients with CUD also have increased intraoperative anesthetic requirements and are, as a result, at increased risk for complications related to a lighter plane of anesthesia, including awareness.
The route of ingestion preferred by the user is important to consider. Much like the hookah, commercially available marijuana is not, as of this writing, produced in the form of ltered cigarettes. Due to the absence of lters signicantly more prod­ucts of combustion such as tar and other carcinogens are inhaled than with com­mercially available ltered tobacco cigarettes [47]. The carboxyhemoglobin level in the blood of a marijuana smoker can be up to ve times higher than that of a tobacco smoker, primarily due to the practice of deep inhalation, holding the smoke in lungs longer [48]. Patients who use marijuana in different forms, other than smoking, are still subject to the effects of the drug. Edibles, tinctures, and other forms of non­inhaled cannabis will still increase in heart rate, produce ectopy, and in patients with underlying coronary vascular disease, can result in reversible ST or T segment abnormalities visible on the perioperative electrocardiogram (ECG). These factors alone can make the safe induction of anesthesia challenging, increase the risk for perioperative MI, and require higher doses of anesthesia to achieve a depth adequate for elective surgery [38, 49].